In the present study, we demonstrated that BBR could ameliorate renal tubulointerstitial fibrosis by inhibiting hyperglycemia-induced EMT via inactivation of NLRP3 inflammasome both in vivo and in vitro. This evidence concerns the gene NLRP3 and Hyperglycemia.